. Histopathologic examination of the cervical LAM revealed caseating granulomas (Fig. 3) . Mycobacterium TB
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Dear Editor: Tuberculosis cutis orificialis (TCO) is a periorifical mucocutaneous disorder usually evolves secondary to active tuberculosis (TB) infection of gastrointestinal, respiratory and genitaurinary system. Orifical TB infection develops due to autoinoculation of bacilli from primary active tuberculous source. TCO has a poor prognosis. It is a sign of advanced TB infections 1 . TCO is a secondary TB infection. 2 ). Histopathologic examination of the cervical LAM revealed caseating granulomas (Fig. 3) . Mycobacterium TB complex was isolated from samples taken from broncoscopic aspiration, broncoalveolar lavage, sputum and gingival ulceration. At the end of ninth month of antituberculous therapy gingival ulceration almost completely healed (Fig. 1B) . Tumour necrosis factor alpha (TNF-alpha) plays a major role in granuloma formation and antituberculous immunity. Medication againt TNF-alpha cytokine increase the risk of TB infection. Risk of TB infection is higher in patients who receives infliximab and ADMB. The TB incidence in patient with etanercept a little bit lower 3 .
Incidence of extrapulmonary and miliary TB (MTB) infection is higher in patient who receives TNF-alpha blockers compare to usual TB infection. Pulmonary symptoms usually not present in those patients. Therefore, diagnosis of TB infection could be delied 4 . Moreover, TB infection in TNF-alpha blocker related immuncompromised patients, usually evolves due to reacitvation of latent mycobactery bacilli. However, in some mathematical modeling studies demostrated that patient with TNF-alpha blockers may reinfected with a new type of mycobacteries which treatment could be complicated 5 . Some studies showes that, developement of TB infection sooner after initiation of TNF-alpha blocker therapy, probably due to reactivation of latent TB, whereas those that occur later may be because of reinfection of new TB 3 . In the prospective of above mentioned knowledges, we can speculate that, in this case, gingival ulceration probably was a primary source of disseminated TB reinfection. Primary Ghom complexes or cavitary lesions in the upper lobes of the lung as a sign of pulmonary TB (PTB) reacitvation was absent in HRCT examination. Furthermore, patient's general health was quite normal, without active upper and lower respiratory symptoms. Therefore, MTB developed probably secondarily to primary TCO at the background of long-lasting and uncontrolled ADMB treatment in this patient. However, the exact differentiation of reinfection and reactivation of TB should be done by DNA fingerprinting of isolated bacilli. Unfortunately, we were unable to implement this kind of test. In this patient TB infection rapidly confirmed by lymph node (LN) histopathology examination (Fig. 3) . Several tissue samples taken from gingival mucosa was unhelpful for diagnosis TBC infection. However, in one sample, giant langhans cells was found similarly to giant cells in LN pathology (Fig. 3) . Nevertheless, the nature of gingival ulceration confirmed by isolation mycobacterium in tissue culture. In the differential diagnosis of gingival ulceration, neoplastic diseases, cronic herpes simplex, Behçet's diseases, autoimmune bullous diseases, inflammatory diseases and other infectious diseases considered in this patient and ruled out. Secondarily TCO due to active PTB was thought in this patient. However, abscence of cavitary lesions in the lung and active pulmonary symptoms made us to think about primary TCO. Probably, gingival ulceration was a primary inoculation side of bacilli as a reinfection phenomenon of TB. MTB evolved in this patient presumably secondarily to gingival ulceration. In MTB, lungs, LN, liver and spleen most common involved organs. Hepatomegaly in 37% cases, splenomegaly in 32% cases could be sign of MTB (Fig. 2 ) 6 . In this case, HSM was considered as part of MTB infection.
In conclusion, by this case we are trying once more emphasize that patients with monoclonal antibody treatment should be closely monitored since they are more vulnerable to TB recurrences wheather by reactivation or reinfection. In this patient, exact differention of reactivation and reinfection of TB infection was not obtained, however by clinical course and radiological examination we thought about primary TCO reinfection due to five year continious ADMB administration. Patients under the treatment of TNF-alpha blockers can show unusual TB presentation with an extrapulmonary predominance like in this case. Therefore, before approvement of TNF-alpha blockers especially monoclonal antibodies, mucocutanoues examination should be performed carefully, since some TB related lesions could be asymptomatic like in this patient.
